Literature DB >> 3385082

The Revised Conners Parent Rating Scale: factor structure replication with a diversified clinical sample.

M Cohen1.   

Abstract

The Revised Conners Teacher Rating Scale was completed as part of a comprehensive evaluation of 135 consecutive new patients seen in the Pediatric Neurology Learning Disability Clinic at the Medical College of Georgia. The questionnaires were subjected to principal components analysis with varimax rotation. Item analysis was conducted on the obtained subscales, and convergent validity was determined by correlation with the Revised Behavior Problem Checklist (Quay & Peterson, 1987). Finally, comparisons of the diagnostic groups were carried out across the subscales.

Entities:  

Mesh:

Year:  1988        PMID: 3385082     DOI: 10.1007/bf00913594

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  7 in total

1.  A teacher rating scale for use in drug studies with children.

Authors:  C K Conners
Journal:  Am J Psychiatry       Date:  1969-12       Impact factor: 18.112

2.  Hyperactivity. Overview and new directions.

Authors:  G Weiss
Journal:  Psychiatr Clin North Am       Date:  1985-12

3.  Evidence for an independent syndrome of hyperactivity.

Authors:  R L Trites; K Laprade
Journal:  J Child Psychol Psychiatry       Date:  1983-10       Impact factor: 8.982

4.  Normative data on revised Conners Parent and Teacher Rating Scales.

Authors:  C H Goyette; C K Conners; R F Ulrich
Journal:  J Abnorm Child Psychol       Date:  1978-06

5.  Factor analysis of the Conners Teacher Rating Scale based on a large normative sample.

Authors:  R L Trites; A G Blouin; K Laprade
Journal:  J Consult Clin Psychol       Date:  1982-10

6.  Conners' Teacher Rating Scale for use in drug studies with children--an empirical study.

Authors:  J S Werry; R L Sprague; M N Cohen
Journal:  J Abnorm Child Psychol       Date:  1975

7.  Psychological sequelae of brain damage in children.

Authors:  M Rutter
Journal:  Am J Psychiatry       Date:  1981-12       Impact factor: 18.112

  7 in total
  6 in total

1.  Quality measures for the care of patients with insomnia.

Authors:  Jack D Edinger; Daniel J Buysse; Ludmila Deriy; Anne Germain; Daniel S Lewin; Jason C Ong; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

2.  Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale - parent form.

Authors:  Susan Shur-Fen Gau; Chi-Yung Shang; Shih-Kai Liu; Chien-Ho Lin; James M Swanson; Yu-Chih Liu; Chang-Ling Tu
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

3.  [Formula: see text]Differences in memory functioning between children with attention-deficit/hyperactivity disorder and/or focal epilepsy.

Authors:  Sylvia E Lee; Michelle Y Kibby; Morris J Cohen; Lisa Stanford; Yong Park; Suzanne Strickland
Journal:  Child Neuropsychol       Date:  2015-07-08       Impact factor: 2.500

4.  Memory functioning in children with reading disabilities and/or attention deficit/hyperactivity disorder: a clinical investigation of their working memory and long-term memory functioning.

Authors:  Michelle Y Kibby; Morris J Cohen
Journal:  Child Neuropsychol       Date:  2008-11       Impact factor: 2.500

Review 5.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Natalia Szejko; Sally Robinson; Andreas Hartmann; Christos Ganos; Nanette M Debes; Liselotte Skov; Martina Haas; Renata Rizzo; Jeremy Stern; Alexander Münchau; Virginie Czernecki; Andrea Dietrich; Tara L Murphy; Davide Martino; Zsanett Tarnok; Tammy Hedderly
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-18       Impact factor: 4.785

Review 6.  Linking irritability and functional brain networks: A transdiagnostic case for expanding consideration of development and environment in RDoC.

Authors:  Ashely N Nielsen; Lauren S Wakschlag; Elizabeth S Norton
Journal:  Neurosci Biobehav Rev       Date:  2021-07-21       Impact factor: 9.052

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.